Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Record of Telephone Conversation, May 8, 2009 - Adenovirus 

Submission Type: Original Application   Submission ID:  125296/0    Office: OVRR  

Adenovirus Vaccine Live Oral Type 4 and Type 7

Duramed Research Inc.          

Telecon Date/Time:  08-MAY-2009 03:40 PM                Initiated by FDA?  Yes
Telephone Number:    610-747-2664

Communication Categorie(s):


Telecon Summary:
Providing information about the PI

FDA Participants:   Daryll Miller

Non-FDA Participants:  John Pakulski 

Trans-BLA Group: No

Related STNs:  None

Related PMCs:  None

Telecon Body:
A message was left on John Pakulski’s office telephone regarding the PI.  We expect to send our first version of the PI by the end of next week (May 15).  Called to let them know that we plan to give the product a Pregnancy Category D due to a literature search which found some articles where Adenovirus was discovered in adverse pregnancy outcomes.  We will speak with him next week regarding this issue.

Page Last Updated: 09/25/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English